A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
NCT07365319
This study is recruiting at 16 US sites in 9 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a study to evaluate the safety and efficacy of EIK1001 administered intravenously in combination with pembrolizumab and histologically appropriate chemotherapy for patients with stage 4 NSCLC.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Non Small Cell Lung Cancer (Squamous or Non Squamous)
- Stage 4 NSCLC
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2/3
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Eikon Therapeutics
- Last updated on ClinicalTrials.gov
- October 2, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- Southern Cancer Center, P.C. · Daphne, AL
California · 2
- Los Angeles Cancer Network · Glendale, CA
- Providence St. Joseph Hospital · Orange, CA
Colorado · 1
- Rocky Mountain Cancer Centers, LLP · Pueblo, CO
Florida · 2
- Florida Clinical Trials Group · Plantation, FL
- Florida Clinical Trials Group - Tamarac · Tamarac, FL
Illinois · 1
- OSF Saint Francis Medical Center · Peoria, IL
New Mexico · 1
- University of New Mexico - Comprehensive Cancer Center · Albuquerque, NM
New York · 4
- NYU Langone Hospital Long Island · Mineola, NY
- NYU Langone Hospital Manhattan · New York, NY
- Jacobi Medical Center - Albert Einstein College of Medicine · The Bronx, NY
- White Plains Hospital · White Plains, NY
Tennessee · 1
- Tennessee Oncology · Nashville, TN
Virginia · 3
- Blue Ridge Cancer Center · Blacksburg, VA
- Virginia Cancer Specialists, PC · Fairfax, VA
- Shenandoah Oncology P.C. · Winchester, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.